Codema Pharma SA
The score of Codema Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +619 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Codema Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −32,963 € | ||||
| Equity | 71,289 € | ||||
| Cash | 2,366 € | ||||
| EBITDA | −34,489 € | ||||
| Total assets | 375,959 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 14 Jul 2025
- Year ended 31 Dec 2023filed on 24 Jul 2024
- Year ended 31 Dec 2022filed on 24 Jul 2023
- Year ended 31 Dec 2021filed on 26 Jul 2022
Codema Pharma's financial analysis
- Solvency19.0%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Codema Pharma
Codema Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0678.830.942
- VAT number
- BE0678830942
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 25 Jul 2017
- Registered office
- 1040 Brussels
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Codema Pharma (SA) has been based in Brussels since 2017, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 32,963 € and equity of 71,289 €; its revenue is not published. Its solvency stands at 19.0%, below the median of its sector (37.8%).
Companies similar to Codema Pharma
Companies in the same business, of comparable size and area, outside its group.
- Jeandarme Manufacture of pharmaceutical preparations Sint-Truiden · balance sheet €1.60m
- Offiplant Retail sale of pharmaceutical products Lessines · balance sheet €3.17m
- Apotheek Herne Retail sale of pharmaceutical products Pajottegem · balance sheet 330,199 €
- Pharmacie MORY Retail sale of pharmaceutical products Saint-Gilles · balance sheet 349,639 €
- Lisanne Moons Retail sale of pharmaceutical products Zonhoven · balance sheet 138,433 €
- Katrien Smets Retail sale of pharmaceutical products Heist-op-den-Berg · balance sheet 56,328 €
- Tannhauser Pharaescos Retail sale of pharmaceutical products Koekelberg · balance sheet 292,153 €
- Novaplex Retail sale of pharmaceutical products Modave · balance sheet 119,122 €
Frequently asked questions about Codema Pharma
What is the revenue of Codema Pharma?
Codema Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Codema Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0678830942 for Codema Pharma, if the company is VAT-registered. Its company number (CBE) is 0678.830.942.
Where is the registered office of Codema Pharma?
According to the CBE register, the registered office of Codema Pharma is in 1040 Brussels.
What is the equity of Codema Pharma?
At the close of the 2025 financial year, the equity of Codema Pharma amounts to 71,289 €, a solvency of 19.0% of total assets.
Who manages Codema Pharma?
The register lists 3 active mandates at Codema Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Codema Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →